ArticleJTO clinical and research reports2024

Synchronous Oligometastasis and Oligoprogression as a Prognostic Marker in Patients With Extensive-Stage SCLC Treated With a Combination of Immune-Checkpoint Inhibitor and Chemotherapy (HOT2301).

Kana Hashimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.